Physician-Investigator, Research Coordinator, and Patient Perspectives on Dual-Role Consent in Oncology
JAMA Network Open · 25.07.2023 · 6 (7) · e2325477
DOI: 10.1001/jamanetworkopen.2023.25477 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 25.07.2023. Verfasst von Stephanie R Morain und 3 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Berman Institute of Bioethics and the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Balt…. Hauptthemen laut MEDLINE: Neoplasms, Physicians. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Importance Classic statements of research ethics generally advise against dual-role consent in which physician-investigators seek consent for research participation from patients with whom they have preexisting treatment relationships. Yet dual-role consent is common in clinical oncology research, as studies are often conducted in close relationship with clinical care.
Objective
To explore key stakeholders’ perspectives on dual-role consent in clinical oncology trials. Design, Setting, and Participants This qualitative study with 43 participants was conducted at a National Cancer Institute–designated comprehensive cancer center from 2018 to 2022. Semistructured qualitative interviews of physician-investigators, research coordinators, and patients were performed. Respondents were recruited from 3 populations: (1) physician-investigators engaged in clinical oncology research; (2) research coordinators engaged in clinical oncology research; and (3) patients, with and without prior clinical trial experience, who had received a new cancer diagnosis at least 2 months prior to enrollment in this study. Main Outcomes and Measures Interviews were audio recorded and professionally transcribed. A thematic analysis approach was used to develop a codebook that included both theory-driven, a priori codes and emergent, inductive codes. Two authors double-coded all transcripts and met regularly to compare coding, discuss discrepancies, refine the codebook, and draft memos describing relevant themes and their frequency.
Results
Among the 43 respondents, 28 (65.1%) were female; 9 (20.9%) were African American, 8 (18.6%) were Asian, 6 (14.0%) were Hispanic, and 21 (48.8%) were White; 15 were physician-investigators (6 [40.0%] with 6-10 years of experience, 4 [26.7%] with at least 20 years of experience), 13 were research coordinators (5 [38.5%] with 0-5 years of experience, 5 [38.5%] with 6-10 years of experience), and 15 were patients (9 [60.0%] aged 46-64 years). Four main themes were found: interviewees (1) perceived greater potential for role synergy than for role conflict; (2) reported dual-role consent as having mixed effects on the consent process, increasing prospective participants’ understanding and likelihood of agreement while also challenging voluntariness; (3) preferred a team-based approach to the consent process in which physician-investigators and research coordinators share responsibility for communicating with prospective participants and safeguarding voluntariness; and (4) offered strategies for managing tensions in dual-role consent. Conclusions and Relevance This qualitative study found that concerns about dual-role consent in clinical oncology, while valid, may be outweighed by corresponding advantages, particularly if appropriate mitigation strategies are in place. These findings support a team-based approach to informed consent, in which physician-investigators and research coordinators promote both the understanding and voluntariness of prospective participants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Johns Hopkins Berman Institute of Bioethics and the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
- Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas.
- Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.
- Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
Förderung
- NCI NIH HHS
Zitieren
APA
Morain, S. R., Barlevy, D., Joffe, S., & Largent, E. A. (2023). Physician-Investigator, Research Coordinator, and Patient Perspectives on Dual-Role Consent in Oncology. JAMA Network Open, 6(7), e2325477. https://doi.org/10.1001/jamanetworkopen.2023.25477
Vancouver
Morain SR, Barlevy D, Joffe S, Largent EA. Physician-Investigator, Research Coordinator, and Patient Perspectives on Dual-Role Consent in Oncology. JAMA Network Open. 2023;6(7):e2325477. doi:10.1001/jamanetworkopen.2023.25477
BibTeX
@article{Morain2023,
author = {Morain, Stephanie R and Barlevy, Dorit and Joffe, Steven and Largent, Emily A},
title = {Physician-Investigator, Research Coordinator, and Patient Perspectives on Dual-Role Consent in Oncology},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {7},
pages = {e2325477},
doi = {10.1001/jamanetworkopen.2023.25477}
}
EUVIMED